ESC Premium Access

Great Debate: anticoagulation for stroke prevention in atrial fibrillation – the grey zone

Event: ESC Congress 2021 - The Digital Experience
Topic: Pharmacology and Pharmacotherapy
Session type: Great Debates
Date: 28 August 2021
Time: 08:00 - 08:45

Session

Become an ESC member to access this resource

Become a member

Already a member? Sign in

3 presentations in this session

Anticoagulation should be given to all patients with atrial fibrillation and CHA2DS2-VASc score of 1: pro.

Speaker: Professor G. Lip (Liverpool, GB)
Thumbnail

Anticoagulation should be given to all patients with atrial fibrillation and CHA2DS2-VASc score of 1: con.

Speaker: Associate Professor A. Niessner (Vienna, AT)
Thumbnail

Great Debate: anticoagulation for stroke prevention in atrial fibrillation – the grey zone – discussion.

Thumbnail

2 speakers from this session

Professor Gregory Yh Lip

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)
61 presentations
3 followers

Associate Professor Alexander Niessner

Medical University of Vienna, Vienna (Austria)
6 presentations
0 follower

Related content

ESC Premium Access

Pregnancy in women with cardiovascular disease

3 December 2021

ESC Premium Access

Current controversies in antithrombotic therapy

3 December 2021

ESC Premium Access

Opening session

2 December 2021

This platform is supported by

logo Novo Nordisk